The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sitagliptin Metformin Hydrochloride Mylan



Mylan Ireland LimitedEU/1/21/1619/001-008

Main Information

Trade NameSitagliptin Metformin Hydrochloride Mylan
Active SubstancesMetformin Hydrochloride
Sitagliptin
Dosage FormFilm-coated tablet
Licence HolderMylan Ireland Limited
Licence NumberEU/1/21/1619/001-008

Group Information

ATC CodeA10BD07 metformin and sitagliptin

Status

License statusAuthorised
Licence Issued16/02/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0070-121-003
Interchangeable List DocumentPDF of Interchangeable List
« Back